11 companies

Daiichi Sankyo Company

Market Cap: JP¥4.9t

Manufactures and sells pharmaceutical products in Japan and internationally.

4568

JP¥2,719.00

7D

4.2%

1Y

-13.3%

GNI Group

Market Cap: JP¥186.2b

Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.

2160

JP¥2,830.00

7D

-0.6%

1Y

-7.5%

PeptiDream

Market Cap: JP¥134.1b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

4587

JP¥1,043.50

7D

-2.0%

1Y

-31.9%

Nxera Pharma

Market Cap: JP¥88.4b

Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.

4565

JP¥955.00

7D

-3.5%

1Y

13.2%

SanBio

Market Cap: JP¥79.9b

Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.

4592

JP¥1,023.00

7D

2.5%

1Y

-50.3%

Heartseed

Market Cap: JP¥37.5b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

219A

JP¥1,640.00

7D

-1.7%

1Y

-49.2%

Healios K.K

Market Cap: JP¥32.5b

Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

4593

JP¥241.00

7D

-4.7%

1Y

-47.5%

StemRIM

Market Cap: JP¥19.4b

A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.

4599

JP¥310.00

7D

-4.3%

1Y

3.0%

Kidswell Bio

Market Cap: JP¥7.4b

Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.

4584

JP¥149.00

7D

4.9%

1Y

-37.7%

Noile-Immune Biotech

Market Cap: JP¥5.5b

Researches and develops CAR-T cells for novel cancer immunotherapies.

4893

JP¥127.00

7D

5.0%

1Y

-27.4%

TMS

Market Cap: JP¥4.7b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

4891

JP¥104.00

7D

-4.6%

1Y

-37.3%